SARS-COV-2 Delta variant displays moderate resistance to neutralizing antibodies and spike protein properties of higher soluble ACE2 sensitivity, enhanced cleavage and fusogenic activity.
bioRxiv
; 2021 Nov 08.
Article
in En
| MEDLINE
| ID: mdl-34790980
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Diagnostic_studies
Language:
En
Journal:
BioRxiv
Year:
2021
Document type:
Article